company background image
DCAL logo

Dishman Carbogen Amcis NSEI:DCAL Voorraadrapport

Laatste prijs

₹218.52

Marktkapitalisatie

₹34.5b

7D

2.8%

1Y

28.8%

Bijgewerkt

21 Nov, 2024

Gegevens

Financiële gegevens bedrijf

Dishman Carbogen Amcis Limited

NSEI:DCAL Voorraadrapport

Marktkapitalisatie: ₹34.5b

DCAL Overzicht aandelen

Dishman Carbogen Amcis Limited levert contractonderzoek en productiediensten voor de farmaceutische industrie, gezondheidszorg en biotechnologie wereldwijd. Meer informatie

Dishman Carbogen Amcis Limited Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Dishman Carbogen Amcis
Historische aandelenkoersen
Huidige aandelenkoers₹218.52
52 Week Hoogtepunt₹283.00
52 Week Laag₹133.00
Bèta1.24
11 maand verandering24.51%
3 maanden verandering14.17%
1 Jaar Verandering28.84%
33 jaar verandering-6.89%
5 jaar verandering62.89%
Verandering sinds IPO-37.93%

Recent nieuws en updates

The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet

Oct 15
The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet

Recent updates

The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet

Oct 15
The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet

Why Investors Shouldn't Be Surprised By Dishman Carbogen Amcis Limited's (NSE:DCAL) 31% Share Price Plunge

Jun 01
Why Investors Shouldn't Be Surprised By Dishman Carbogen Amcis Limited's (NSE:DCAL) 31% Share Price Plunge

Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Feb 25
Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Dec 29
Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Is Dishman Carbogen Amcis (NSE:DCAL) Using Too Much Debt?

Jun 22
Is Dishman Carbogen Amcis (NSE:DCAL) Using Too Much Debt?

Is Dishman Carbogen Amcis (NSE:DCAL) A Risky Investment?

Feb 14
Is Dishman Carbogen Amcis (NSE:DCAL) A Risky Investment?

Dishman Carbogen Amcis (NSE:DCAL) Use Of Debt Could Be Considered Risky

Jun 22
Dishman Carbogen Amcis (NSE:DCAL) Use Of Debt Could Be Considered Risky

Shareholders Will Be Pleased With The Quality of Dishman Carbogen Amcis' (NSE:DCAL) Earnings

May 18
Shareholders Will Be Pleased With The Quality of Dishman Carbogen Amcis' (NSE:DCAL) Earnings

Dishman Carbogen Amcis (NSE:DCAL) Has A Pretty Healthy Balance Sheet

Mar 14
Dishman Carbogen Amcis (NSE:DCAL) Has A Pretty Healthy Balance Sheet

We Think Dishman Carbogen Amcis (NSE:DCAL) Is Taking Some Risk With Its Debt

Aug 23
We Think Dishman Carbogen Amcis (NSE:DCAL) Is Taking Some Risk With Its Debt

Why Dishman Carbogen Amcis Limited (NSE:DCAL) Could Be Worth Watching

Apr 29
Why Dishman Carbogen Amcis Limited (NSE:DCAL) Could Be Worth Watching

Dishman Carbogen Amcis (NSE:DCAL) Has A Somewhat Strained Balance Sheet

Mar 16
Dishman Carbogen Amcis (NSE:DCAL) Has A Somewhat Strained Balance Sheet

A Look At Dishman Carbogen Amcis' (NSE:DCAL) Share Price Returns

Feb 23
A Look At Dishman Carbogen Amcis' (NSE:DCAL) Share Price Returns

How Much Are Dishman Carbogen Amcis Limited (NSE:DCAL) Insiders Spending On Buying Shares?

Feb 05
How Much Are Dishman Carbogen Amcis Limited (NSE:DCAL) Insiders Spending On Buying Shares?

Is Dishman Carbogen Amcis Limited (NSE:DCAL) Popular Amongst Institutions?

Jan 23
Is Dishman Carbogen Amcis Limited (NSE:DCAL) Popular Amongst Institutions?

What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Jan 10
What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Is Now An Opportune Moment To Examine Dishman Carbogen Amcis Limited (NSE:DCAL)?

Dec 23
Is Now An Opportune Moment To Examine Dishman Carbogen Amcis Limited (NSE:DCAL)?

Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Dec 05
Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Dishman Carbogen Amcis Limited (NSE:DCAL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Nov 17
Dishman Carbogen Amcis Limited (NSE:DCAL) Shares Could Be 27% Below Their Intrinsic Value Estimate

If You Had Bought Dishman Carbogen Amcis' (NSE:DCAL) Shares Three Years Ago You Would Be Down 47%

Oct 23
If You Had Bought Dishman Carbogen Amcis' (NSE:DCAL) Shares Three Years Ago You Would Be Down 47%

What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Sep 27
What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Is Now The Time To Look At Buying Dishman Carbogen Amcis Limited (NSE:DCAL)?

Sep 06
Is Now The Time To Look At Buying Dishman Carbogen Amcis Limited (NSE:DCAL)?

Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Could Signal Some Risk

Aug 03
Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Could Signal Some Risk

Dishman Carbogen Amcis Limited's (NSE:DCAL) Price In Tune With Earnings

Jul 20
Dishman Carbogen Amcis Limited's (NSE:DCAL) Price In Tune With Earnings

Market Cool On Dishman Carbogen Amcis Limited's (NSE:DCAL) Earnings

Jul 06
Market Cool On Dishman Carbogen Amcis Limited's (NSE:DCAL) Earnings

Rendement voor aandeelhouders

DCALIN Life SciencesIN Markt
7D2.8%1.2%0.3%
1Y28.8%48.2%27.3%

Rendement versus industrie: DCAL presteerde slechter dan de Indian Life Sciences -sector, die het afgelopen jaar een rendement van 48.2 % opleverde.

Rendement versus markt: DCAL overtrof de Indian markt, die het afgelopen jaar een rendement opleverde van 27.3 %.

Prijsvolatiliteit

Is DCAL's price volatile compared to industry and market?
DCAL volatility
DCAL Average Weekly Movement8.7%
Life Sciences Industry Average Movement6.5%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market4.0%

Stabiele aandelenkoers: De aandelenkoers van DCAL is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 9% ) van DCAL is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen Indian.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19831,132Arpit Vyasimdcal.com

Dishman Carbogen Amcis Limited levert contractonderzoek en productiediensten voor de farmaceutische industrie, gezondheidszorg en biotechnologie wereldwijd. Het bedrijf is actief via de segmenten Contract Research and Manufacturing Services en Marketable Molecules. Het produceert en levert ook medicijnen in bulk, actieve farmaceutische ingrediënten (API's) en algemene en zeer krachtige API's; speciale chemicaliën bestaande uit tussenproducten, fijnchemicaliën, fosforanen, vaste quaternaire ammoniumverbindingen, wittig reagentia en diverse farmaceutische en cosmetica-gerelateerde producten; vitamine D-producten en analogen daarvan; hand- en lichaamswasmiddelen, ontsmettingsmiddelen en antiseptica; en katalysatoren voor faseoverdracht, zachte gelcapsules, ontsmettingsformules, cholesterol, lanoline-gerelateerde producten en vloeibare en gevriesdroogde steriele injecteerbare producten.

Dishman Carbogen Amcis Limited Samenvatting

Hoe verhouden de winst en inkomsten van Dishman Carbogen Amcis zich tot de beurswaarde?
DCAL fundamentele statistieken
Marktkapitalisatie₹34.49b
Inkomsten(TTM)-₹1.74b
Inkomsten(TTM)₹26.19b

1.3x

P/S-verhouding

-19.7x

Koers/Winstverhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
DCAL resultatenrekening (TTM)
Inkomsten₹26.19b
Kosten van inkomsten₹7.25b
Brutowinst₹18.93b
Overige uitgaven₹20.68b
Inkomsten-₹1.74b

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)-11.10
Brutomarge72.31%
Nettowinstmarge-6.65%
Schuld/Eigen Vermogen Verhouding37.7%

Hoe presteerde DCAL op de lange termijn?

Bekijk historische prestaties en vergelijking